Enzyme assay | Frontiers in Congenital Disorders of Glycosylation

Skip to main content

Search

Join Our Contact Registry

RDCRN Alumni badge

Header Social Media

Our Research
Patients and Families
Researchers and Clinicians
Early Stage Investigators
News and Events
- Latest News
About Us

A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium

A test that is done to measure a protein’s activity to determine how efficient the protein is in biochemical reactions.

Footer menu

Web Policies
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) is a previously funded research group of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). FCDGC received funding under grant number U54NS115198 as a collaboration between NCATS, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Office of Dietary Supplements (ODS). This website is hosted by the network's Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the FCDGC administrative coordinating center at Icahn School of Medicine at Mount Sinai, New York, and does not necessarily represent the official views of the NIH.